Ischaemic conditioning: Pitfalls on the path to clinical translation

Research output: Contribution to journalReview articlepeer-review

29 Scopus citations


The development of novel adjuvant strategies capable of attenuating myocardial ischaemia-reperfusion injury and reducing infarct size remains a major, unmet clinical need. A wealth of preclinical evidence has established that ischaemic 'conditioning' is profoundly cardioprotective, and has positioned the phenomenon (in particular, the paradigms of postconditioning and remote conditioning) as the most promising and potent candidate for clinical translation identified to date. However, despite this preclinical consensus, current phase II trials have been plagued by heterogeneity, and the outcomes of recent meta-analyses have largely failed to confirm significant benefit. As a result, the path to clinical application has been perceived as 'disappointing' and 'frustrating'. The goal of the current review is to discuss the pitfalls that may be stalling the successful clinical translation of ischaemic conditioning, with an emphasis on concerns regarding: (i) appropriate clinical study design and (ii) the choice of the 'right' preclinical models to facilitate clinical translation.

Original languageEnglish
Pages (from-to)1961-1973
Number of pages13
JournalBritish Journal of Pharmacology
Issue number8
StatePublished - Apr 1 2015


Dive into the research topics of 'Ischaemic conditioning: Pitfalls on the path to clinical translation'. Together they form a unique fingerprint.

Cite this